Anti-hypertensive drugs, especially angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs), may reduce CRC incidence due to their inhibition of the hormone angiotensin II, which has been shown to promote cell proliferation, angiogenesis, inflammation, and metastasis [9]. Here, ACE is linked to colorectal carcinoma.